Evaluation of the effects of A-PRF and oral dexamethasone use on postoperative complications in third molar extraction: a split-mouth randomized-controlled trial

MakaleAçık Erişim
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Background: The aim of this study was to compare the effects of advanced platelet-rich-fibrin (A-PRF) and oral dexamethasone on postoperative complications in patients undergoing impacted mandibular third molar extraction. Methods: This split-mouth, prospective, randomized-controlled study involved bilateral extraction of impacted mandibular third molars. A-PRF was applied to the extraction socket on one side, while postoperative oral dexamethasone was prescribed for the other side. Data were collected on pain, edema, trismus, and analgesic consumption. Intra-group and inter-group comparisons were performed. The Visual Analog Scale (VAS) was used for pain assessment. The patients were given a form to record their postoperative analgesic use. Pain assessments were conducted at postoperative 3, 6, 9, 12, 24 h, and on Days 2, 3, 4, 5, 6, 7, 14, and 30. Maximum interincisal distance was measured for trismus evaluation, while facial measurements between specific points were taken for edema assessment. Trismus and edema measurements were conducted on postoperative Days 2, 7, 14, and 30. Results: This study included 30 patients with bilateral impacted mandibular third molars (total of 60 extractions). The VAS scores were significantly lower on the side treated with oral dexamethasone compared to the A-PRF side at all measurement times (p < 0.01). Considering edema evaluation, measurements were similar between both sides at all time points except on Day 2, when the A-PRF side showed significantly higher values (p = 0.001 and p < 0.01). For trismus evaluation, maximum interincisal distance was significantly greater on the oral dexamethasone side on Days 2 and 7 compared to the A-PRF side (p = 0.001 and p < 0.01). Analgesic consumption was significantly higher in the A-PRF group than in the oral dexamethasone group at all measured time points between 12 h and Day 7 (p < 0.01). Conclusion: Oral dexamethasone appeared to be more effective than A-PRF in reducing postoperative complications. However, no significant difference was observed between the two groups in edema on Days 7, 14, and 30. Although not as effective as oral dexamethasone, A-PRF, being an autologous product with no side effects, can still be considered for reducing complications following impacted tooth extraction. Trial Registration: The study was retrospectively registered at ClinicalTrials.gov with the number of NCT06823934, Registration date 02 June 2025.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/adakent/10065Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1186/s12903-026-09135-3Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorElbahisi, Youssef Hazza Mohamed
dc.contributor.authorKeskin Tunç, Serap
dc.contributor.authorBaşkan Önal, Aslı
dc.contributor.authorBaydar, Sava
dc.date.accessioned2026-10-21T19:30:41.284927295Z
dc.date.available2026-10-21T19:30:41.284927295Z
dc.date.issued2026
dc.description.abstractBackground: The aim of this study was to compare the effects of advanced platelet-rich-fibrin (A-PRF) and oral dexamethasone on postoperative complications in patients undergoing impacted mandibular third molar extraction. Methods: This split-mouth, prospective, randomized-controlled study involved bilateral extraction of impacted mandibular third molars. A-PRF was applied to the extraction socket on one side, while postoperative oral dexamethasone was prescribed for the other side. Data were collected on pain, edema, trismus, and analgesic consumption. Intra-group and inter-group comparisons were performed. The Visual Analog Scale (VAS) was used for pain assessment. The patients were given a form to record their postoperative analgesic use. Pain assessments were conducted at postoperative 3, 6, 9, 12, 24 h, and on Days 2, 3, 4, 5, 6, 7, 14, and 30. Maximum interincisal distance was measured for trismus evaluation, while facial measurements between specific points were taken for edema assessment. Trismus and edema measurements were conducted on postoperative Days 2, 7, 14, and 30. Results: This study included 30 patients with bilateral impacted mandibular third molars (total of 60 extractions). The VAS scores were significantly lower on the side treated with oral dexamethasone compared to the A-PRF side at all measurement times (p < 0.01). Considering edema evaluation, measurements were similar between both sides at all time points except on Day 2, when the A-PRF side showed significantly higher values (p = 0.001 and p < 0.01). For trismus evaluation, maximum interincisal distance was significantly greater on the oral dexamethasone side on Days 2 and 7 compared to the A-PRF side (p = 0.001 and p < 0.01). Analgesic consumption was significantly higher in the A-PRF group than in the oral dexamethasone group at all measured time points between 12 h and Day 7 (p < 0.01). Conclusion: Oral dexamethasone appeared to be more effective than A-PRF in reducing postoperative complications. However, no significant difference was observed between the two groups in edema on Days 7, 14, and 30. Although not as effective as oral dexamethasone, A-PRF, being an autologous product with no side effects, can still be considered for reducing complications following impacted tooth extraction. Trial Registration: The study was retrospectively registered at ClinicalTrials.gov with the number of NCT06823934, Registration date 02 June 2025.
dc.identifier.articlenumber1901
dc.identifier.doi10.1186/s12903-026-09135-3
dc.identifier.issn1472-6831
dc.identifier.issue1
dc.identifier.pmid42421033
dc.identifier.scopus2-s2.0-105052389292
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/adakent/10065
dc.identifier.volume26
dc.identifier.wosWOS:001893937900002
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofBMC Oral Health
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectA-PRF
dc.subjectDexamethasone
dc.subjectImpacted wisdom teeth
dc.subjectOral dexamethasone
dc.subjectOral surgery
dc.subjectPostoperative Complications
dc.subjectThird Molar
dc.subjectTooth extraction
dc.subject.classificationDentistry, Oral Surgery & Medicine
dc.subject.otherAdministration, Oral
dc.subject.otherAdult
dc.subject.otherAnti-Inflammatory Agents
dc.subject.otherDexamethasone
dc.subject.otherEdema
dc.subject.otherFemale
dc.subject.otherHumans
dc.subject.otherMale
dc.subject.otherMandible
dc.subject.otherMolar, Third
dc.subject.otherPain Measurement
dc.subject.otherPostoperative Complications
dc.subject.otherPostoperative Pain
dc.subject.otherProspective Studies
dc.subject.otherTooth Extraction
dc.subject.otherTooth, Impacted
dc.subject.otherTrismus
dc.subject.otherYoung Adult
dc.subject.otherantiinflammatory agent
dc.subject.othercontrolled study
dc.subject.otherhuman
dc.subject.otheroral drug administration
dc.subject.otherpostoperative complication
dc.subject.otherprevention and control
dc.subject.otherprospective study
dc.subject.otherrandomized controlled trial
dc.subject.othersurgery
dc.subject.otherthird molar
dc.subject.othertooth impaction
dc.titleEvaluation of the effects of A-PRF and oral dexamethasone use on postoperative complications in third molar extraction: a split-mouth randomized-controlled trial
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex0
rdl.citation.scopus0
rdl.citation.wos0
rdl.oa.statusgold
rdl.oa.urlhttps://doi.org/10.1186/s12903-026-09135-3
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)